⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144716 | 0.81 | — | — | |
| SCHEMBL20378 | 0.76 | — | — | |
| SCHEMBL5473595 | 0.76 | CA1 (0.36) | — | |
| SCHEMBL31299613 | 0.72 | — | — | |
| Water SCHEMBL27835182 | 0.72 | — | — | |
| SCHEMBL2864068 | 0.72 | — | — | |
| Lithium SCHEMBL31299618 | 0.72 | — | — | |
| Potassium SCHEMBL31299624 | 0.72 | — | — | |
| SCHEMBL11795560 | 0.72 | — | — | |
| SCHEMBL27964256 | 0.72 | LDHA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0666753-B9 | Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES | PEPTECH LTD (AU) | 2002-06-12 | — | — | EP | claimed |
| EP-0666753-B1 | Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES | PEPTECH LIMITED (AU) | 2000-11-22 | — | — | EP | claimed |